Inotek Pharma (ITEK) Trades to Session Highs Following Trabodenoson, Analyst Commentary
Tweet Send to a Friend
Inotek Pharma (NASDAQ: ITEK) shares are ramping to session highs following today's trabodenoson update and analyst commentary.Earlier, Inotek announced the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE